Evaluation of the therapeutic efficacy and tolerability of levocarnitine propionyl in the treatment of chronic obstructive arteriopathies of the lower extremities: a multicentre controlled study vs. placebo.

@article{Coto1992EvaluationOT,
  title={Evaluation of the therapeutic efficacy and tolerability of levocarnitine propionyl in the treatment of chronic obstructive arteriopathies of the lower extremities: a multicentre controlled study vs. placebo.},
  author={Vincenzo Coto and Luigi D'Alessandro and G Grattarola and L Imparato and M Lingetti and Mario Mancini and Giuseppe Nolfe and Franco Rengo},
  journal={Drugs under experimental and clinical research},
  year={1992},
  volume={18 1},
  pages={29-36}
}
The treatment of symptomatic chronic obstructive peripheral arteriopathies is a difficult task since it requires the prolonged administration of drugs which are often unable to correct the various pathogenetic factors reponsible for the disability. The authors, on the basis of recent studies demonstrating the rheological and vasoactive as well as metabolic activities of levocarnitine propionyl, have decided to use this substance in the treatment of arteriopathics affected by intermittent… CONTINUE READING